Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study
Ziyuan Yi, Zhuoran Huang, Caixia Duan, Xinru Hu, Dongyang Chen, Jie Zhang, Kuancheng Liu, Xiangjun Du, Caijun Sun, Guangyu Huang · 2026
Read Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study by Ziyuan Yi, Zhuoran Huang, Caixia Duan, Xinru Hu, Dongyang Chen, Jie Zhang, Kuancheng Liu, Xiangjun Du, Caijun Sun, Guangyu Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13611868.txt.
Description
Ziyuan Yi and co-authors chart in this 2026 study how a hepatitis B marker falls week by week on interferon therapy. Clearing the surface antigen for good is the field's prize, and its early slide hints at who will win it. Records of 533 patients on interferon alone or with one of three partner pills were matched and modeled over twenty-four weeks.
Paths varied wildly, some even rising early. Low starting levels and fast early drops foretold clearance. Adding a pill matched interferon alone overall, though small subgroup splits appeared by sex and immune state. The authors back weekly checks to steer care per patient. Clinics can act on a stall by week four.
Catalog record
| CREATOR | Ziyuan Yi, Zhuoran Huang, Caixia Duan, Xinru Hu, Dongyang Chen, Jie Zhang, Kuancheng Liu, Xiangjun Du, Caijun Sun, Guangyu Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |